This inventor holds 3 USPTO granted patents. Top assignee: Becton Dickinson and Company Limited. Active years: 1998-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Palo Alto, CA (US) (2000)
- Fremont, CA (US) (1998 - 2003)
Company Filing History:
Years Active: 1998-2003
Title: **Fridtjof Lund-Johansen: Innovator in Hematopoietic Progenitor Cell Research**
Introduction
Fridtjof Lund-Johansen is a distinguished inventor based in Fremont, CA, known for his significant contributions to the field of hematopoietic progenitor cells. With three patents to his name, Lund-Johansen continues to push the boundaries of scientific understanding and application in cell biology.
Latest Patents
Lund-Johansen's latest patents include a groundbreaking method to distinguish hematopoietic progenitor cells. This invention explores the expression of various cell adhesion molecules and growth factor receptors on human progenitor cells, such as CD34/CD38, enabling researchers to identify and isolate different progenitor cell populations. Another notable patent focuses on the differentiation of granulocytic and monocytic progenitor cells. This innovation emphasizes the role of M-CSF responsiveness and M-CSFR expression in discriminating between these cell types, providing insights into their lineage-specific characteristics.
Career Highlights
Lund-Johansen works with Becton Dickinson and Company Limited, where his research directly impacts the company's innovative approach to medical technologies and cellular therapies. His patents not only contribute to scientific literature but also hold the potential for practical applications in clinical settings, enhancing how researchers and medical professionals approach cell differentiation and treatment strategies.
Collaborations
Throughout his career, Lund-Johansen has collaborated with esteemed colleagues, including Johanna Olweus and Leon W Terstappen. These partnerships highlight the collaborative nature of scientific research, fostering an environment where ideas can flourish and lead to groundbreaking discoveries.
Conclusion
Fridtjof Lund-Johansen's work is a testament to the importance of innovation in understanding complex biological systems. His contributions to hematopoietic progenitor cell research are not only instrumental in advancing scientific knowledge but also pave the way for future developments in medical applications. As he continues his work at Becton Dickinson and Company Limited, the impact of his inventions will undoubtedly resonate throughout the field of cell biology for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile